Al Rihani S, Deodhar M, Dow P, Turgeon J, Michaud VJAoP, Research P. (2020) Is Dexamethasone a Substrate, an Inducer, or a Substrate-Inducer of CYP3As. Iris Publishers.
Baillie TA, Dalvie D, Rietjens IM, Cyrus Khojasteh SJDMR. (2015) Biotransformation and bioactivation reactions–literature highlights. Drug Metabolism Reviews 48(2):113-138.
Crake RL, Strother MR, Phillips E, Doogue MP, Zhang M, Frampton C, et al. (2021) Influence of serum inflammatory cytokines on cytochrome P450 drug metabolising activity during breast cancer chemotherapy: a patient feasibility study. Nature Journal 11(1):1-11.
Di Nola A, Roccatano D, Berendsen HJJPS, Function, Bioinformatics. (1994) Molecular dynamics simulation of the docking of substrates to proteins. Wiley Online library 19(3):174-82.
Gong EC, Chea S, Balupuri A, Kang NS, Chin YW, Choi YH. (2018) Enzyme kinetics and molecular docking studies on cytochrome 2B6, 2C19, 2E1, and 3A4 activities by sauchinone. Molecules. Natinal Library of Medicine 2;23(3):555.
Goodwin B, Hodgson E, Liddle C. (1999) The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Molecular pharmacology 1;56(6):1329-39.
Goodwin B, Redinbo MR, Kliewer SAJArop, toxicology.( 2002) Regulation of cyp3a gene transcription by the pregnane x receptor. ANNUAL REVIEWS 42:1-23.
Gujjula S, Jayasree D, Swamy PY. (2018) MOLECULAR MODELLING AND MOLECULAR DOCKING STUDIES OF CYP450 INHIBITORS. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH 1;9(5):1895-901.
Kino T, Manoli I, Kelkar S, Wang Y, Su YA, Chrousos GPJB, et al.( 2009) Glucocorticoid receptor (GR) β has intrinsic, GRα-independent transcriptional activity. Natinal Library of Medicine 381(4):671-675.
Koe X, Muhammad T, Chong A, Wahab H, Tan M. (2014) Cytochrome P450 induction properties of food and herbal-derived compounds using a novel multiplex RT-qPCR in vitro assay, a drug–food interaction prediction tool. Food Science & Nutrition, 500-520 PP.
Kozakov D, Hall DR, Xia B, Porter KA, Padhorny D, Yueh C, et al. (2017) The ClusPro web server for protein–protein docking. Natinal Library of Medicine 12(2):255-278.
LIDDLE C, GOODWIN B, GEORGE J, TAPNER M, FARRELL G. (1998) Separate and Interactive Regulation of Cytochrome P450 3A4 by Triiodothyronine, Dexamethasone, and Growth Hormone in Cultured Hepatocytes. Journal of Clinical Endocrinology and Metabolism Copyright,2411-2416 PP.
Lu NZJPR. ( 2006) The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors. Natinal Library of Medicine 58(4):782-97.
Pascussi JM, Drocourt L, Gerbal‐Chaloin S, Fabre JM, Maurel P, Vilarem MJJEjob. ( 2001) Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes: sequential role of glucocorticoid receptor and pregnane X receptor. Natinal Library of Medicine 268(24):6346-58.
Prieto-Martínez FD, Arciniega M, Medina-Franco JLJTReecq-b. (2018) Molecular docking: current advances and challenges. ResearchGate 21.
Sadus RJ. (2002) Molecular simulation of fluids: Elsevier.
Vardhan S, Sahoo SK.(2020) In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19. Computers in biology and medicine 1;124:103936.
Villikka K, Kivistö KT, Neuvonen PJJP, toxicology. (1998) The effect of dexamethasone on the pharmacokinetics of triazolam.
Pharmacology & Toxicology 83(3):135-8.
Zerilli A, Lucas D, Dreano Y, Picart D, Berthou F. (1998) Effect of Pyrazole and Dexamethasone Administration on Cytochrome P450 2El and 3A Isoforms in Rat Liver and Kidney: Lack of Specificity of p-Nitrophenol as a Substrate of P450 2El. SM: CLINICALND EXPERIMENTAL REFEAR, 652-657 PP.
Zerilli A, Lucas D, Dreano Y, Picart D, Berthou FJAC, Research E. (1998) Effect of Pyrazole and Dexamethasone Administration on Cytochrome P450 2E1 and 3A Isoforms in Rat Liver and Kidney: Lack of Specificity of p‐Nitrophenol as a Substrate of P450 2E1. CLINICAL & EXPERIMENTAL RESEARCH 22(3):652-7.
